1 |
7-beta-Hydroxyepiandrosterone
| 1件: 7-beta-Hydroxyepiandrosterone 7-beta-Hydroxyepiandrosterone | - | - | - | 1件: 6 6 |
2 |
8-hydroxy-2'-deoxyguanosine
| 1件: 8-OHdG 8-OHdG | - | - | - | 1件: 6 6 |
3 |
Acamprosate
| 1件: Acamprosate Acamprosate | 2件: D02780
D02780
,
D07058
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
4 |
Acetaminophen
| 5件: Acetaminophen Acetaminophen; Oxycodone/Acetaminophen; Paracetamol; Tylenol; Ultracet | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 18件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
5 |
Acetate
| 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
6 |
Acetohydroxamic acid
| 1件: Acetohydroxamic Acid Acetohydroxamic Acid | 1件: D00220
D00220
| - | - | 2件: 6 6, 251 |
7 |
Acetylcysteine
| 3件: Acetylcysteine Acetylcysteine; Mucomyst; N-acetylcysteine | 1件: D00221
D00221
| - | - | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
8 |
ACR325
| 1件: ACR325 ACR325 | - | - | - | 1件: 6 6 |
9 |
Activated charcoal
| 1件: Carbon Carbon | - | - | - | 9件: 6 6, 46, 50, 51, 85, 86, 96, 97, 298 |
10 |
Ademetionine
| 2件: SAM-e SAM-e; SAMe | 1件: D07128
D07128
| - | - | 2件: 6 6, 93 |
11 |
Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins
| 1件: HB-adMSCs HB-adMSCs | - | - | - | 7件: 2 2, 4, 6, 13, 46, 49, 113 |
12 |
Agomelatine
| 1件: Agomelatine Agomelatine | 1件: D02578
D02578
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
13 |
Alanine
| 2件: Alanine Alanine; L-alanine | 1件: D00012
D00012
| - | - | 5件: 6 6, 13, 251, 298, 299 |
14 |
Albendazole
| 2件: Albendazole Albendazole; Eskazole | 1件: D00134
D00134
| - | - | 12件: 5 5, 6, 7, 13, 28, 51, 67, 86, 96, 97, 114, 127 |
15 |
Allopurinol
| 2件: Allopurinol Allopurinol; ALLOPURINOL SODIUM | 1件: D00224
D00224
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 6件: 6 6, 46, 57, 66, 96, 97 |
16 |
Altropane
| 1件: Altropane Altropane | - | - | - | 1件: 6 6 |
17 |
Amantadine
| 3件: Amantadine Amantadine; AMANTADINE HYDROCHLORIDE; GOCOVRI | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 |
18 |
Ambroxol
| 1件: Ambroxol Ambroxol | 1件: D07442
D07442
| - | - | 2件: 6 6, 19 |
19 |
Amoxicillin
| 4件: Amoxicilina Amoxicilina; AMOXICILLIN; Amoxycillin; Augmentin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 9件: 6 6, 19, 46, 63, 84, 96, 97, 222, 299 |
20 |
Ampicillin
| 1件: ABPC ABPC | 3件: D00204
D00204
,
D01251
,
D02119
| - | - | 5件: 2 2, 6, 13, 84, 299 |
21 |
Ampreloxetine
| 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
22 |
anle138b
| 1件: Anle138b Anle138b | - | - | - | 1件: 6 6 |
23 |
ANX-510
| 0件: | - | - | - | 3件: 6 6, 265, 288 |
24 |
Aplindore
| 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 |
25 |
Apomorphine
| 3件: APOKYN APOKYN; Apomorfina; Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 |
26 |
Aripiprazole
| 1件: Aripiprazole Aripiprazole | 1件: D01164
D01164
| 4件: DRD2 DRD2, DRD3, HTR1A, HTR2A 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
27 |
Armodafinil
| 2件: Armodafinil Armodafinil; Modafinil | 1件: D03215
D03215
| 1件: SLC6A3 SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 |
28 |
Aspartame
| 0件: | 1件: D02381
D02381
| 2件: TAS1R2 TAS1R2, TAS1R3 💬 | 2件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Taste transduction 💬 | 5件: 6 6, 13, 67, 86, 230 |
29 |
Atomoxetine
| 2件: Atomoxetine Atomoxetine; Strattera | 2件: D02574
D02574
,
D07473
| 1件: SLC6A2 SLC6A2 💬 | 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 |
30 |
AV-101
| 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 |
31 |
Azathioprine
| 3件: Azathioprine Azathioprine; AZATIOPRINA; Imuran | 2件: D00238
D00238
,
D03033
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
32 |
AZD-0328
| 0件: | - | - | - | 1件: 6 6 |
33 |
Bavisant
| 1件: Bavisant Bavisant | 1件: D09870
D09870
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
34 |
Benserazide
| 1件: BENSERAZIDE BENSERAZIDE | 1件: D03082
D03082
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
35 |
Benzofuran
| 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 |
36 |
BIA
| 1件: BIA BIA | - | - | - | 2件: 6 6, 86 |
37 |
Bifenthrin
| 1件: CAPTURE CAPTURE | - | - | - | 2件: 6 6, 46 |
38 |
Biomodulin T
| 0件: | - | - | - | 4件: 6 6, 96, 97, 98 |
39 |
Botulinum toxin type A
| 8件: Botox Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 13件: 2 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
40 |
Botulinum toxin type B
| 3件: Botulinum toxin type B Botulinum toxin type B; NEUROBLOC; RimabotulinumtoxinB | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 2 2, 6, 13, 51 |
41 |
Bromocriptine
| 1件: BROMOCRIPTINE BROMOCRIPTINE | 2件: D00780
D00780
,
D03165
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 74 |
42 |
BTRX-246040
| 1件: BTRX-246040 BTRX-246040 | - | - | - | 1件: 6 6 |
43 |
Bumetanide
| 1件: Bumetanide Bumetanide | 1件: D00247
D00247
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 158 |
44 |
Buspirone
| 2件: Buspirone Buspirone; Buspirone Hydrochloride | 2件: D00702
D00702
,
D07593
| 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 |
45 |
Butylphthalide
| 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
46 |
Cabergoline
| 3件: CABERGOLINA CABERGOLINA; Cabergoline; DOSTINEX | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 74, 75 |
47 |
Caffeine
| 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 2 2, 6, 13, 21, 46, 78, 96, 97, 265 |
48 |
Calcium
| 2件: Calcio Calcio; Calcium | - | - | - | 30件: 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
49 |
Cannabidiol
| 3件: CANNABIDIOL CANNABIDIOL; Epidyolex; Sativex | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 19件: 2 2, 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
50 |
Capsaicin
| 2件: Capsaicin Capsaicin; Qutenza | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 5件: 2 2, 6, 19, 86, 226 |
51 |
Captopril
| 1件: Captopril Captopril | 1件: D00251
D00251
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 |
52 |
Carbidopa
| 7件: Carbidopa Carbidopa; DUODOPA; Lodosyn; PARCOPA; SINEMET; SINEMET CR; Stalevo | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
53 |
Carbon monoxide
| 1件: Carbon monoxide Carbon monoxide | 1件: D09706
D09706
| - | - | 8件: 6 6, 13, 53, 70, 85, 86, 149, 298 |
54 |
Carnosine
| 1件: Carnosine Carnosine | - | - | - | 2件: 6 6, 13 |
55 |
Carvedilol
| 1件: CARVEDILOL CARVEDILOL | 2件: D00255
D00255
,
D03415
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 57, 86, 113, 210 |
56 |
Ceftriaxone
| 1件: Ceftriaxone Ceftriaxone | 2件: D00924
D00924
,
D07659
| - | - | 3件: 2 2, 6, 97 |
57 |
CEP-1347
| 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 |
58 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 29件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
59 |
Cholecalciferol
| 5件: Cholecalciferol Cholecalciferol; COLECALCIFEROL; Multivitamin; Vitamin D; Vitamin D3 | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 25件: 6 6, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 |
60 |
Citalopram
| 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
61 |
Citicoline
| 1件: Citicolina Citicolina | 1件: D00057
D00057
| - | - | 1件: 6 6 |
62 |
Clarithromycin
| 1件: CLARITHROMYCIN CLARITHROMYCIN | 1件: D00276
D00276
| - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
63 |
Clenbuterol
| 1件: Clenbuterol Clenbuterol | 1件: D07713
D07713
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 1 1, 2, 6, 13, 256 |
64 |
Clonazepam
| 1件: Clonazepam Clonazepam | 1件: D00280
D00280
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
65 |
Clonidine
| 4件: Clonidin Clonidin; Clonidina; Clonidine; CLONIDINE HYDROCHLORIDE | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 65, 70, 78 |
66 |
Clozapine
| 1件: CLOZAPINE CLOZAPINE | 1件: D00283
D00283
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 8件: Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
67 |
Cobalt chloride
| 1件: Ceretec Ceretec | - | - | - | 1件: 6 6 |
68 |
Cocoa
| 2件: Chocolate Chocolate; Cocoa | - | - | - | 1件: 6 6 |
69 |
Creatine
| 1件: Creatine Creatine | - | - | - | 16件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
70 |
Cyanocobalamin
| 2件: Cianocobalamina Cianocobalamina; Vitamin B12 | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 5件: 6 6, 13, 201, 229, 299 |
71 |
Cycloserine
| 0件: | 1件: D00877
D00877
| - | - | 1件: 6 6 |
72 |
Cysteine
| 2件: Cysteine Cysteine; Cysteine hydrochloride | 2件: D00026
D00026
,
D02326
| - | - | 11件: 6 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 |
73 |
D-Serine
| 1件: D-Serine D-Serine | - | - | - | 1件: 6 6 |
74 |
Dalfampridine
| 7件: 4-Aminopyridine 4-Aminopyridine; 4-AP; Ampyra; Dalfampridine; FAMPRIDINA; FAMPRIDINE; FAMPYRA | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 5件: 3 3, 4, 6, 13, 14 |
75 |
Darifenacin
| 2件: Darifenacin Darifenacin; Emselex | 2件: D01699
D01699
,
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
76 |
Deanol
| 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
77 |
Deferiprone
| 2件: Deferiprone Deferiprone; Ferriprox | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
78 |
Delorazepam
| 0件: | 1件: D07784
D07784
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 46, 97 |
79 |
Desmopressin
| 5件: DDAVP DDAVP; Desmopressin; Desmopressin Acetate; Desmopressine; Minirin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 6件: 6 6, 64, 72, 75, 225, 288 |
80 |
Dexmedetomidine
| 4件: Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
81 |
Dextromethorphan
| 4件: Dextromethorphan Dextromethorphan; DEXTROMETHORPHAN HYDROBROMIDE; Dextrometorfano; Nuedexta | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
82 |
Dextrose, unspecified form
| 2件: Dextrose Dextrose; Glucose | - | - | - | 19件: 2 2, 6, 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 226, 254, 257, 299 |
83 |
Dichloroisoproterenol
| 0件: | - | - | - | 2件: 6 6, 299 |
84 |
Dihydroergotoxine
| 1件: Dihydroergotoxine Dihydroergotoxine | 1件: D07839
D07839
| - | - | 1件: 6 6 |
85 |
Dihydrotachysterol
| 0件: | 1件: D00299
D00299
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 6 6, 85 |
86 |
Dipivefrin
| 2件: Dipivefrin Dipivefrin; Dipivefrine | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
87 |
Dipraglurant
| 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 |
88 |
Doconexent
| 1件: Docosahexaenoic acid Docosahexaenoic acid | - | - | - | 10件: 6 6, 46, 48, 49, 90, 94, 113, 240, 299, 301 |
89 |
Domperidone
| 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
90 |
Donepezil
| 3件: ARICEPT ARICEPT; Donepezil; Donepezil hydrochloride | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
91 |
Dopamine
| 2件: Dopamina Dopamina; Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 6 6, 7, 74, 299 |
92 |
Doxepin
| 1件: Doxepin Doxepin | 2件: D00814
D00814
,
D07875
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
93 |
Droxidopa
| 4件: DOPS DOPS; Droxidopa; L-DOPS; Northera | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
94 |
Duloxetine
| 3件: CYMBALTA CYMBALTA; Duloxetine; Duloxetine hydrochloride | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
95 |
Eliprodil
| 1件: Eliprodil Eliprodil | - | - | - | 1件: 6 6 |
96 |
Elobixibat
| 1件: Elobixibat Elobixibat | 1件: D10796
D10796
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 6 6 |
97 |
Eltoprazine
| 1件: ELTOPRAZINE ELTOPRAZINE | - | - | - | 1件: 6 6 |
98 |
Entacapone
| 5件: COMTAN COMTAN; Comtess; ENTACAPONA; ENTACAPONE; Stalevo | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
99 |
EPI-589
| 1件: EPI-589 EPI-589 | - | - | - | 2件: 2 2, 6 |
100 |
Epigallocatechin gallate
| 2件: EGCG EGCG; Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
101 |
Ergoloid mesylate
| 2件: Dihydroergotoxine Mesylate Dihydroergotoxine Mesylate; Ergoloid Mesylate | 1件: D02268
D02268
| 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 206 |
102 |
Erythromycin
| 1件: Erythromycin Erythromycin | 9件: D00140
D00140
,
D00851
,
D01361
,
D02009
,
D02184
,
D02523
,
D02524
,
D02525
,
D04054
| - | - | 5件: 6 6, 36, 164, 228, 291 |
103 |
Erythropoietin
| 4件: Epoetin alfa Epoetin alfa; Epoetin beta; Erythropoietin; Neorecormon | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 10件: 2 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 |
104 |
Escitalopram
| 3件: Citalopram Citalopram; Escitalopram; Escitalopram oxalate | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 |
105 |
Eszopiclone
| 2件: Eszopiclone Eszopiclone; Zopiclone | 1件: D02624
D02624
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 46 |
106 |
Etomidate
| 1件: Etomidate Etomidate | 1件: D00548
D00548
| 1件: GABRA1 GABRA1 💬 | 6件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | 1件: 6 6 |
107 |
Exametazime
| 1件: Exametazime Exametazime | 1件: D01109
D01109
| - | - | 1件: 6 6 |
108 |
Exenatide
| 3件: Bydureon Bydureon; Byetta; Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 |
109 |
Famotidine
| 2件: FAMOTIDINA FAMOTIDINA; Famotidine | 1件: D00318
D00318
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 7件: 6 6, 46, 61, 86, 98, 107, 300 |
110 |
Febuxostat
| 1件: Febuxostat Febuxostat | 1件: D01206
D01206
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 3件: 2 2, 6, 13 |
111 |
Fenamole
| 0件: | 1件: D04139
D04139
| - | - | 3件: 6 6, 13, 160 |
112 |
Fesoterodine
| 1件: Fesoterodine Fesoterodine | 1件: D07226
D07226
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
113 |
Filgrastim
| 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; GRANULOCYTE COLONY STIMULATING FACTOR; Neupogen; TEVAGRASTIM; Zarzio | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件: 2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
114 |
Finasteride
| 1件: Finasteride Finasteride | 1件: D00321
D00321
| 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
115 |
Fipamezole
| 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
116 |
Flecainide
| 3件: Flecainide Flecainide; FLECAINIDE ACETATE; Flecainidum | 2件: D00638
D00638
,
D07962
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
117 |
Florbenazine F-18
| 1件: 18F-AV-133 18F-AV-133 | - | - | - | 1件: 6 6 |
118 |
Florbetaben (18F)
| 2件: FLORBETABEN (18F) FLORBETABEN (18F); Neuraceq | - | - | - | 1件: 6 6 |
119 |
Fludeoxyglucose (18F)
| 3件: 18F-FDG 18F-FDG; Fludeoxyglucose; Fludeoxyglucose F 18 | - | - | - | 14件: 5 5, 6, 7, 8, 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 |
120 |
Fludrocortisone
| 1件: Fludrocortisone Fludrocortisone | 2件: D00986
D00986
,
D07967
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
121 |
Flumazenil
| 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
122 |
Flutemetamol
| 1件: Flutemetamol Flutemetamol | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
123 |
Flutemetamol (18F)
| 3件: Flutemetamol Flutemetamol; Flutemetamol F18; Vizamyl | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
124 |
Folic acid
| 5件: Acide folique Acide folique; Folate; Folic Acid; Multivitamin; NICOTINAMIDE | 1件: D00070
D00070
| - | - | 6件: 6 6, 13, 41, 46, 49, 84 |
125 |
Foliglurax
| 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
126 |
Foscarbidopa
| 1件: Foscarbidopa Foscarbidopa | 1件: D12057
D12057
| - | - | 1件: 6 6 |
127 |
Foslevodopa
| 1件: Foslevodopa Foslevodopa | 1件: D11839
D11839
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
128 |
Furosemide
| 2件: Furosemide Furosemide; Furosemide Injection | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
129 |
Gabapentin
| 4件: Gabapentin Gabapentin; GABAPENTINA; Gabapentine; NEURONTIN | 1件: D00332
D00332
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 19, 70, 298 |
130 |
Galantamine
| 2件: GALANTAMINE GALANTAMINE; Galantamine hydrobromide | 2件: D02173
D02173
,
D04292
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 127 |
131 |
gamma-Hydroxybutyric acid
| 1件: Oxybate Oxybate | - | - | - | 2件: 6 6, 149 |
132 |
Ginkgo biloba
| 3件: Ginkgo Ginkgo; Ginkgo biloba; Tanakan | - | - | - | 5件: 6 6, 13, 18, 47, 90 |
133 |
Glutathione
| 2件: GLUTATHIONE GLUTATHIONE; Reduced glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
134 |
Glycerin
| 3件: Bee venom Bee venom; Glycerine; Glycerol | 1件: D00028
D00028
| - | - | 6件: 6 6, 13, 79, 265, 316, 317 |
135 |
Glycerol phenylbutyrate
| 3件: Glycerol Phenylbutyrate Glycerol Phenylbutyrate; GT4P; Ravicti | 1件: D10127
D10127
| - | - | 3件: 6 6, 251, 299 |
136 |
Gold
| 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
137 |
GPI-1485
| 0件: | - | - | - | 1件: 6 6 |
138 |
Grapefruit
| 1件: Grapefruit Grapefruit | - | - | - | 5件: 6 6, 46, 50, 83, 97 |
139 |
Green tea leaf
| 4件: Green Tea Green Tea; Green Tea Extract; GREEN TEA LEAF; Tea Extract | 1件: D06903
D06903
| - | - | 5件: 6 6, 17, 28, 46, 96 |
140 |
Guar gum
| 1件: Guar gum Guar gum | 1件: D04403
D04403
| - | - | 1件: 6 6 |
141 |
Heptaminol
| 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
142 |
Hydrocortisone
| 6件: Cortef Cortef; Cortisol; Cortisone; Hydrocortisone; Hydrocortisone cream; Hydrocortisonum | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 11件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 98, 299 |
143 |
Hydrocortisone cypionate
| 1件: Cortef Cortef | 1件: D00976
D00976
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 |
144 |
Hydrocortisone succinate
| 2件: HYDROCORTISONE HYDROGEN SUCCINATE HYDROCORTISONE HYDROGEN SUCCINATE; Solu-Cortef | 1件: D01442
D01442
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 |
145 |
Hydrogen
| 2件: Dihydrogen Dihydrogen; Hydrogen | - | - | - | 8件: 5 5, 6, 13, 17, 65, 83, 97, 226 |
146 |
Idebenone
| 2件: Idebenone Idebenone; Raxone | 1件: D01750
D01750
| - | - | 6件: 6 6, 8, 13, 18, 113, 302 |
147 |
Inosine
| 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 6件: 2 2, 6, 13, 17, 85, 122 |
148 |
Interleukin-1 alpha, human recombinant
| 1件: None None | - | - | - | 13件: 6 6, 46, 51, 65, 84, 85, 96, 97, 140, 161, 231, 271, 299 |
149 |
Iodide I-123
| 2件: I 123 I 123; I-123 | - | - | - | 2件: 2 2, 6 |
150 |
Ioflupane I-123
| 3件: DaTscan DaTscan; Ioflupane; Ioflupane I 123 | - | - | - | 4件: 2 2, 5, 6, 17 |
151 |
Ipratropium
| 1件: Ipratropium Ipratropium | 1件: D02212
D02212
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
152 |
Iproniazid
| 1件: IPRONIAZID IPRONIAZID | 1件: D02579
D02579
| 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
153 |
Isoflurane
| 1件: Isoflurane Isoflurane | 1件: D00545
D00545
| - | - | 1件: 6 6 |
154 |
Isoxaflutole
| 1件: Balance Balance | - | - | - | 8件: 6 6, 11, 13, 81, 113, 122, 149, 299 |
155 |
Isradipine
| 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
156 |
Istradefylline
| 1件: ISTRADEFYLLINE ISTRADEFYLLINE | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
157 |
ITI-214
| 1件: ITI-214 ITI-214 | - | - | - | 1件: 6 6 |
158 |
Josamycin
| 0件: | 1件: D01235
D01235
| - | - | 2件: 6 6, 13 |
159 |
Ketamine
| 2件: KETAMINE KETAMINE; NMDA | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 |
160 |
Lactobacillus casei
| 2件: Fusion Fusion; Lactobacillus casei | 1件: D04351
D04351
| - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 |
161 |
Lactobacillus delbrueckii bulgaricus
| 1件: Lactobacillus Lactobacillus | - | - | - | 5件: 6 6, 46, 51, 97, 299 |
162 |
Lactobacillus plantarum
| 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 3件: 6 6, 97, 156 |
163 |
Lactose
| 1件: Lactose Lactose | 2件: D00046
D00046
,
D03226
| - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
164 |
Lenomorelin
| 1件: Ghrelin Ghrelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 |
165 |
Leptin
| 1件: Leptin Leptin | - | - | - | 2件: 6 6, 265 |
166 |
Leucine
| 2件: L-leucine L-leucine; Leucine | 1件: D00030
D00030
| - | - | 11件: 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
167 |
Levetiracetam
| 2件: KEPPRA KEPPRA; Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
168 |
Levodopa
| 8件: DUODOPA DUODOPA; Inbrija; L-DOPA; LEVODOPA; PARCOPA; SINEMET; SINEMET CR; Stalevo | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
169 |
Levomefolic acid
| 1件: L-methylfolate L-methylfolate | 1件: D09353
D09353
| - | - | 1件: 6 6 |
170 |
Liatermin
| 2件: Liatermin Liatermin; R-metHuGDNF | 1件: D04727
D04727
| - | - | 1件: 6 6 |
171 |
Lidocaine
| 4件: Aloe Aloe; Lidocaine; Lignocaine; Xylocaine | 3件: D00358
D00358
,
D02086
,
D08127
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 13件: 6 6, 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 |
172 |
Linaclotide
| 1件: Linaclotide Linaclotide | 1件: D09355
D09355
| 1件: GUCY2C GUCY2C 💬 | 2件: Metabolic pathways Metabolic pathways, Purine metabolism 💬 | 2件: 6 6, 97 |
173 |
Linoleic acid
| 1件: Linoleic acid Linoleic acid | - | - | - | 8件: 2 2, 5, 6, 13, 75, 76, 222, 299 |
174 |
Liraglutide
| 2件: LIRAGLUTIDE LIRAGLUTIDE; Saxenda | 1件: D06404
D06404
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 75, 193 |
175 |
Lisuride
| 1件: LISURIDE LISURIDE | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
176 |
Lithium citrate
| 2件: Lithium Lithium; LITHIUM CITRATE | 1件: D04749
D04749
| - | - | 5件: 2 2, 5, 6, 7, 8 |
177 |
Lixisenatide
| 1件: Lixisenatide Lixisenatide | 1件: D09729
D09729
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
178 |
Lovastatin
| 1件: Lovastatin Lovastatin | 1件: D00359
D00359
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 |
179 |
Lubiprostone
| 1件: Lubiprostone Lubiprostone | 1件: D04790
D04790
| 1件: CLCN2 CLCN2 💬 | 1件: Mineral absorption Mineral absorption 💬 | 4件: 6 6, 13, 290, 299 |
180 |
Magnesium
| 1件: Magnesium Magnesium | - | - | - | 21件: 3 3, 6, 11, 13, 15, 46, 51, 64, 70, 93, 97, 111, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
181 |
Magnesium oxide
| 1件: Magnesium oxide Magnesium oxide | 1件: D01167
D01167
| - | - | 3件: 6 6, 166, 291 |
182 |
Maltodextrin
| 1件: Maltodextrin Maltodextrin | 1件: D02329
D02329
| - | - | 4件: 6 6, 13, 96, 97 |
183 |
Manganese citrate
| 1件: Release Release | - | - | - | 12件: 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
184 |
Mannitol
| 4件: Aridol Aridol; Bronchitol; Mannite; MANNITOL | 1件: D00062
D00062
| - | - | 7件: 6 6, 13, 28, 60, 96, 113, 299 |
185 |
Masitinib
| 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
186 |
Mavoglurant
| 1件: Mavoglurant Mavoglurant | - | - | - | 2件: 6 6, 206 |
187 |
Medical Cannabis
| 3件: Cannabis Cannabis; Marijuana; Medical Cannabis | - | - | - | 9件: 2 2, 6, 13, 19, 46, 90, 96, 97, 271 |
188 |
Medium-chain triglycerides
| 3件: Medium chain triglyceride Medium chain triglyceride; Smofkabiven; SMOFLipid | - | - | - | 5件: 6 6, 66, 96, 296, 318 |
189 |
Melatonin
| 2件: Circadin Circadin; MELATONIN | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
190 |
Melevodopa
| 1件: Melevodopa Melevodopa | 1件: D07304
D07304
| - | - | 1件: 6 6 |
191 |
Melperone
| 1件: Melperone Melperone | 1件: D07309
D07309
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
192 |
Memantine
| 3件: Ebixa Ebixa; Memantine; MEMANTINE HYDROCHLORIDE | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 6, 8, 13, 49, 127, 205 |
193 |
Mesdopetam
| 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 |
194 |
Metformin
| 5件: Metformin Metformin; Metformin HCl; Metformin hydrochloride; METFORMINA; Metformine | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
195 |
Methylphenidate
| 3件: Methylphenidate Methylphenidate; METHYLPHENIDATE HYDROCHLORIDE; Ritalin | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 7件: 6 6, 13, 34, 84, 113, 179, 206 |
196 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
197 |
Midazolam
| 2件: Midazolam Midazolam; Midazolam injection | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
198 |
Midodrine
| 2件: Midodrine Midodrine; MIDODRINE HYDROCHLORIDE | 2件: D01307
D01307
,
D08220
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 17, 58 |
199 |
Minocycline
| 3件: Minocycline Minocycline; MINOCYCLINE HYDROCHLORIDE; Minomycin | 2件: D00850
D00850
,
D05045
| - | - | 14件: 2 2, 6, 8, 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 |
200 |
Minodronic acid
| 2件: Minodronate Minodronate; Minodronic acid | - | - | - | 4件: 6 6, 46, 93, 95 |
201 |
Mirabegron
| 1件: Mirabegron Mirabegron | 1件: D09535
D09535
| 1件: ADRB3 ADRB3 💬 | 8件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 |
202 |
Mitoquinone
| 1件: Mitoquinone Mitoquinone | - | - | - | 3件: 6 6, 13, 97 |
203 |
Moclobemide
| 1件: MOCLOBEMIDE MOCLOBEMIDE | 1件: D02561
D02561
| 1件: MAOA MAOA 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
204 |
Modafinil
| 2件: Modafinil Modafinil; Provigil | 1件: D01832
D01832
| - | - | 5件: 6 6, 13, 49, 93, 113 |
205 |
Montelukast
| 3件: Montelukast Montelukast; MONTELUKAST SODIUM; Singulair | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 |
206 |
Moxifloxacin
| 2件: Moxifloxacin Moxifloxacin; Moxifloxacin Hydrochloride | 2件: D00874
D00874
,
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
207 |
Muscimol
| 1件: Muscimol Muscimol | - | - | - | 1件: 6 6 |
208 |
Nabilone
| 1件: Nabilone Nabilone | 1件: D05099
D05099
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 6 6, 13 |
209 |
Nadolol
| 1件: Nadolol Nadolol | 1件: D00432
D00432
| 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
210 |
Nalmefene
| 1件: Nalmefene Nalmefene | 1件: D05111
D05111
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
211 |
Naloxone
| 2件: Naloxone Naloxone; NALOXONE HYDROCHLORIDE | 2件: D01340
D01340
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 226 |
212 |
Naltrexone
| 2件: Naltrexone Naltrexone; Naltrexone Hydrochloride | 2件: D02095
D02095
,
D05113
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 13件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 |
213 |
Nebicapone
| 1件: Nebicapone Nebicapone | - | - | - | 1件: 6 6 |
214 |
Nelotanserin
| 1件: Nelotanserin Nelotanserin | 1件: D09645
D09645
| 1件: HTR2A HTR2A 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
215 |
Neridronic Acid
| 1件: Neridronic Acid Neridronic Acid | - | - | - | 1件: 6 6 |
216 |
Niacin
| 2件: Niacin Niacin; Nicotinic acid | 1件: D00049
D00049
| - | - | 4件: 6 6, 78, 79, 265 |
217 |
Nicotinamide
| 4件: Ginseng Ginseng; Multivitamin; Niacinamide; NICOTINAMIDE | 1件: D00036
D00036
| - | - | 11件: 2 2, 5, 6, 13, 18, 49, 65, 67, 107, 162, 191 |
218 |
Nicotinamide riboside
| 1件: Nicotinamide Riboside Nicotinamide Riboside | - | - | - | 4件: 2 2, 6, 18, 191 |
219 |
Nicotine
| 2件: Nicotine Nicotine; Nicotine gum | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 6 6, 13, 84 |
220 |
Nilotinib
| 2件: Nilotinib Nilotinib; Tasigna | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 6 6, 8, 34, 51, 86 |
221 |
Nitisinone
| 2件: Nitisinone Nitisinone; Orfadin | 1件: D05177
D05177
| 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 3件: 6 6, 164, 241 |
222 |
Nitric Oxide
| 3件: INOmax INOmax; Nitric Oxide; Nitrosyl | 1件: D00074
D00074
| - | - | 16件: 6 6, 13, 46, 58, 85, 86, 96, 97, 98, 210, 222, 226, 251, 294, 299, 321 |
223 |
Nitrogen
| 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 6件: 5 5, 6, 17, 171, 211, 299 |
224 |
Nortriptyline
| 2件: Nortriptyline Nortriptyline; Nortriptyline hydrochloride | 2件: D00816
D00816
,
D08288
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 |
225 |
Omeprazole
| 5件: Losec Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 16件: 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
226 |
Ondansetron
| 1件: Ondansetron Ondansetron | 2件: D00456
D00456
,
D00678
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 4件: 6 6, 97, 107, 231 |
227 |
Opicapone
| 2件: Ongentys Ongentys; OPICAPONE | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
228 |
Oxybuprocaine
| 1件: Oxybuprocaine Oxybuprocaine | 2件: D01768
D01768
,
D08319
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
229 |
Oxybutynin
| 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 13, 53 |
230 |
Oxycodone
| 3件: Oxycodone Oxycodone; OXYCODONE HYDROCHLORIDE; Oxycodone/Acetaminophen | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 13, 46, 70, 226, 231, 298 |
231 |
Oxygen
| 3件: Medical air Medical air; Nitrogen; Oxygen | 1件: D00003
D00003
| - | - | 20件: 6 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330 |
232 |
Oxytocin
| 2件: Oxytocin Oxytocin; Syntocinon | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 72, 127, 193, 206, 226 |
233 |
Pardoprunox
| 1件: Pardoprunox Pardoprunox | 1件: D09397
D09397
| 3件: DRD2 DRD2, DRD3, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
234 |
Paroxetine
| 1件: Paroxetine Paroxetine | 4件: D02260
D02260
,
D02362
,
D05374
,
D05375
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
235 |
Perampanel
| 2件: Fycompa Fycompa; Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 6, 144 |
236 |
Pergolide
| 1件: PERGOLIDE PERGOLIDE | 2件: D00502
D00502
,
D08339
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
237 |
Phenelzine
| 1件: Nardil Nardil | 2件: D00505
D00505
,
D08349
| 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
238 |
Phenylbutyric acid
| 4件: 4-phenylbutyrate 4-phenylbutyrate; Pheburane; Phenylbutyrate; Sodium phenylbutyrate | - | - | - | 14件: 2 2, 3, 6, 8, 15, 21, 93, 94, 231, 244, 251, 297, 299, 338 |
239 |
Phosphate ion
| 1件: Phosphate Phosphate | - | - | - | 33件: 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
240 |
Phosphatidyl serine
| 0件: | 1件: D04682
D04682
| - | - | 4件: 6 6, 46, 90, 97 |
241 |
Piclozotan
| 1件: Piclozotan Piclozotan | - | - | - | 1件: 6 6 |
242 |
Pilocarpine
| 2件: Pilocarpine Pilocarpine; Pilocarpine Hydrochloride | 3件: D00525
D00525
,
D02200
,
D05478
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
243 |
Pimavanserin
| 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
244 |
Pioglitazone
| 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
245 |
Piribedil
| 1件: Piribedil Piribedil | 1件: D07305
D07305
| 2件: DRD2 DRD2, DRD3 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
246 |
Pitolisant
| 1件: Pitolisant Pitolisant | 1件: D10749
D10749
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 113, 193 |
247 |
Pittsburgh Compound B
| 2件: C-11 PiB C-11 PiB; Pittsburgh Compound B | - | - | - | 2件: 6 6, 127 |
248 |
Plantago seed
| 2件: Psyllium Psyllium; Psyllium husk | 1件: D05525
D05525
| - | - | 3件: 6 6, 28, 97 |
249 |
Polyethylene glycol
| 4件: Macrogol Macrogol; Macrogol 4000; Polyethylene glycol; Polyethylene Glycol 3350 | 1件: D03370
D03370
| - | - | 14件: 6 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 235, 240, 276, 299 |
250 |
Posiphen
| 1件: Posiphen Posiphen | - | - | - | 1件: 6 6 |
251 |
Potassium carbonate
| 0件: | 1件: D02038
D02038
| - | - | 3件: 6 6, 96, 291 |
252 |
Pramipexole
| 7件: Mirapex Mirapex; Mirapex ER; Mirapexin; Pramipexol; PRAMIPEXOLE; PRAMIPEXOLE DIHYDROCHLORIDE; SIFROL | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
253 |
Prasinezumab
| 1件: Prasinezumab Prasinezumab | 1件: D11420
D11420
| 1件: SNCA SNCA 💬 | 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
254 |
Prednisone
| 3件: Prednisona Prednisona; Prednisone; RAYOS | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
255 |
Preladenant
| 1件: Preladenant Preladenant | 1件: D09717
D09717
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
256 |
Pridopidine
| 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 8 |
257 |
Propanoic acid
| 1件: Propanoic acid Propanoic acid | 1件: D02310
D02310
| - | - | 2件: 6 6, 271 |
258 |
Propofol
| 2件: PROPOFOL PROPOFOL; Propofol Injection | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 10件: 6 6, 21, 22, 34, 46, 70, 75, 84, 98, 296 |
259 |
Propranolol
| 3件: Propanolol Propanolol; Propranolol; Propranolol Hydrochloride | 2件: D00483
D00483
,
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 158, 167, 215, 227, 278, 296 |
260 |
Psilocybin
| 2件: Psilocybin Psilocybin; Psilocybine | - | - | - | 1件: 6 6 |
261 |
Pyridostigmine
| 3件: Mestinon Mestinon; Pyridostigmine; Pyridostigmine Bromide | 1件: D00487
D00487
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 4件: 3 3, 6, 11, 256 |
262 |
Pyridoxine
| 2件: Pyridoxine Pyridoxine; Vitamin B6 | 2件: D02179
D02179
,
D08454
| - | - | 5件: 6 6, 93, 145, 206, 320 |
263 |
Pyrimethamine
| 2件: Daraprim Daraprim; PYRIMETHAMINE | 1件: D00488
D00488
| - | - | 11件: 2 2, 4, 6, 13, 19, 46, 51, 65, 96, 97, 265 |
264 |
Quetiapine
| 2件: Quetiapine Quetiapine; Seroquel | 2件: D00458
D00458
,
D08456
| 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 2件: 6 6, 13 |
265 |
Raclopride
| 1件: Raclopride Raclopride | - | - | - | 4件: 5 5, 6, 7, 17 |
266 |
Radotinib
| 1件: Radotinib Radotinib | - | - | - | 1件: 6 6 |
267 |
Ramelteon
| 2件: Ramelteon Ramelteon; ROZEREM | 1件: D02689
D02689
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 8, 46 |
268 |
Rasagiline
| 4件: Azilect Azilect; Rasagilina; Rasagiline; RASAGILINE MESYLATE | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 7件: 2 2, 5, 6, 13, 17, 58, 66 |
269 |
Remifentanil
| 2件: Remifentanil Remifentanil; Remifentanyl | 2件: D01177
D01177
,
D08473
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 70 |
270 |
Repaglinide
| 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 3件: 6 6, 21, 299 |
271 |
Reynoutria multiflora root
| 1件: Heshouwu Heshouwu | - | - | - | 1件: 6 6 |
272 |
Rifampicin
| 2件: Rifampicin Rifampicin; Rifampin | 1件: D00211
D00211
| - | - | 9件: 6 6, 13, 17, 46, 84, 86, 93, 299, 338 |
273 |
Rifaximin
| 3件: RIFAXIMIN RIFAXIMIN; RIFAXIMINA; Xifaxan | 1件: D02554
D02554
| - | - | 8件: 6 6, 65, 93, 94, 96, 97, 99, 296 |
274 |
Rituximab
| 6件: MabThera MabThera; Rituxan; RITUXIMAB; Rixathon; Ruxience; Truxima | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
275 |
Rivastigmine
| 3件: Exelon Exelon; RIVASTIGMINE; Rivastigmine Transdermal System | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 5 5, 6, 13 |
276 |
Ropinirole
| 3件: REQUIP REQUIP; ROPINIROLE; Ropinirole Hydrochloride | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 2 2, 6, 74, 309 |
277 |
Rosuvastatin
| 3件: Crestor Crestor; Rosuvastatin; Rosuvastatin calcium | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
278 |
Rotigotine
| 3件: NEUPRO NEUPRO; ROTIGOTINA; Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 127 |
279 |
Safinamide
| 3件: Safinamida Safinamida; SAFINAMIDE; Xadago | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
280 |
Sage
| 1件: Sage Sage | - | - | - | 1件: 6 6 |
281 |
Saracatinib
| 1件: Saracatinib Saracatinib | 1件: D09664
D09664
| 2件: ABL1 ABL1, SRC 💬 | 49件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 3件: 6 6, 89, 272 |
282 |
Sarcosine
| 1件: Sarcosine Sarcosine | - | - | - | 1件: 6 6 |
283 |
Sargramostim
| 2件: Leukine Leukine; Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 |
284 |
Sarizotan
| 1件: SARIZOTAN SARIZOTAN | - | - | - | 2件: 6 6, 156 |
285 |
Selegiline
| 2件: SELEGILINE SELEGILINE; Zelapar | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
286 |
Semaglutide
| 1件: Semaglutide Semaglutide | 1件: D10025
D10025
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
287 |
SEP-363856
| 1件: SEP-363856 SEP-363856 | - | - | - | 1件: 6 6 |
288 |
Serine
| 2件: L-Serine L-Serine; Serine | 1件: D00016
D00016
| - | - | 4件: 2 2, 6, 86, 96 |
289 |
Sertraline
| 1件: Sertraline Sertraline | 2件: D00825
D00825
,
D02360
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 206 |
290 |
Sevoflurane
| 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
291 |
Sildenafil
| 6件: Mysildecard Mysildecard; Revatio; Sildenafil; SILDENAFIL CITRATE; SILDENAFILO; Viagra | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
292 |
Silicon
| 1件: Silicon Silicon | - | - | - | 1件: 6 6 |
293 |
Silodosin
| 2件: Silodosin Silodosin; Silodyx | 1件: D01965
D01965
| 1件: ADRA1A ADRA1A 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 13 |
294 |
Simvastatin
| 3件: Simvastatin Simvastatin; Simvastatina; Simvastatine | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
295 |
Sirolimus
| 3件: Rapamune Rapamune; Rapamycin; Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 41件: 2 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
296 |
Sitagliptin
| 1件: Sitagliptin Sitagliptin | 1件: D08516
D08516
| 1件: DPP4 DPP4 💬 | 1件: Protein digestion and absorption Protein digestion and absorption 💬 | 4件: 6 6, 75, 233, 299 |
297 |
Smilagenin
| 1件: SMILAGENIN SMILAGENIN | - | - | - | 1件: 6 6 |
298 |
Sodium chloride
| 6件: Lactated Ringers Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; SPORANOX | 1件: D02056
D02056
| - | - | 21件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
299 |
Sodium oxybate
| 1件: Sodium Oxybate Sodium Oxybate | 1件: D05866
D05866
| - | - | 2件: 6 6, 149 |
300 |
Solifenacin
| 2件: Solifenacin Solifenacin; Solifenacin Succinate | 2件: D01269
D01269
,
D08522
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 3件: 6 6, 13, 53 |
301 |
Sorbitol
| 3件: D-glucitol D-glucitol; D-SORBITOL; Sorbitol | 1件: D00096
D00096
| - | - | 4件: 6 6, 10, 28, 299 |
302 |
Sulfachlorpyridazine
| 0件: | 1件: D05948
D05948
| - | - | 1件: 6 6 |
303 |
Sulfanilamide
| 0件: | 1件: D08543
D08543
| - | - | 5件: 6 6, 30, 60, 118, 298 |
304 |
Sulfate ion
| 1件: Sulfate Sulfate | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
305 |
Sulforaphane
| 1件: Sulforaphane Sulforaphane | - | - | - | 2件: 6 6, 205 |
306 |
Sulpiride
| 0件: | 2件: D01226
D01226
,
D08549
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 2 2, 6, 17, 46, 70 |
307 |
Sumanirole
| 1件: Sumanirole Sumanirole | - | - | - | 1件: 6 6 |
308 |
Suvorexant
| 1件: Suvorexant Suvorexant | 1件: D10082
D10082
| 2件: HCRTR1 HCRTR1, HCRTR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 5 5, 6, 13 |
309 |
Tacrolimus
| 2件: Prograf Prograf; Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
310 |
Tadalafil
| 4件: Adcirca Adcirca; CIALIS; Tadalafil; TADALAFILO | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 |
311 |
Talampanel
| 1件: Talampanel Talampanel | 1件: D02696
D02696
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
312 |
Tavapadon
| 2件: PF-06649751 PF-06649751; TAVAPADON | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
313 |
Technetium Tc-99m exametazime
| 1件: Ceretec Ceretec | - | - | - | 1件: 6 6 |
314 |
Terazosin
| 1件: Terazosin Terazosin | 2件: D00610
D00610
,
D08569
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
315 |
Tesofensine
| 1件: TESOFENSINE TESOFENSINE | - | - | - | 2件: 6 6, 193 |
316 |
Tolcapone
| 3件: Tasmar Tasmar; Tolcapon; TOLCAPONE | 1件: D00786
D00786
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 3件: 6 6, 28, 127 |
317 |
Topiramate
| 2件: TOPAMAX TOPAMAX; Topiramate | 1件: D00537
D00537
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 97, 140, 144, 156, 193 |
318 |
Topramezone
| 0件: | - | - | - | 8件: 6 6, 13, 46, 50, 53, 96, 97, 299 |
319 |
Tozadenant
| 1件: TOZADENANT TOZADENANT | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
320 |
Trichloroethylene
| 0件: | - | - | - | 1件: 6 6 |
321 |
Tricyclazole
| 1件: Beam Beam | - | - | - | 2件: 6 6, 51 |
322 |
Trihexyphenidyl
| 1件: Trihexyphenidyl Trihexyphenidyl | 2件: D00787
D00787
,
D08638
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 5 5, 6 |
323 |
Trimethobenzamide
| 3件: Tigan Tigan; Trimethobenzamide; Trimethobenzamide Hydrochloride | 2件: D02733
D02733
,
D08643
| - | - | 1件: 6 6 |
324 |
Tropicamide
| 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 13, 19 |
325 |
Tryptophan
| 2件: Propanoic acid Propanoic acid; Tryptophan | 1件: D00020
D00020
| - | - | 2件: 6 6, 75 |
326 |
Tulobuterol
| 1件: Tulobuterol Tulobuterol | 1件: D02151
D02151
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
327 |
Tyramine
| 1件: Tyramine Tyramine | - | - | - | 1件: 6 6 |
328 |
Tyrosine
| 4件: Alanine Alanine; L-tyrosine; Propanoic acid; Tyrosine | 1件: D00022
D00022
| - | - | 5件: 6 6, 75, 86, 111, 298 |
329 |
Ubidecarenone
| 3件: Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | 1件: D01065
D01065
| - | - | 13件: 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 193, 214, 215 |
330 |
Ubiquinol
| 1件: Ubiquinol Ubiquinol | - | - | - | 3件: 6 6, 8, 17 |
331 |
Umbilical Cord Blood Hematopoietic Stem Cells
| 1件: Cord blood therapy Cord blood therapy | - | - | - | 2件: 2 2, 6 |
332 |
Uric acid
| 1件: Urate Urate | - | - | - | 1件: 6 6 |
333 |
Ursodeoxycholic acid
| 4件: UDCA UDCA; URSODEOXYCHOLIC ACID; Ursodiol; Ursofalk | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 14件: 6 6, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 |
334 |
Valerian
| 1件: Valerian Valerian | - | - | - | 1件: 6 6 |
335 |
Valproic acid
| 3件: Valproate Valproate; VALPROATE SODIUM; Valproic Acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
336 |
Varenicline
| 2件: Champix Champix; VARENICLINE | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 2件: 6 6, 18 |
337 |
Venglustat
| 2件: GENZ-682452 GENZ-682452; Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 6 6, 19, 67 |
338 |
Venlafaxine
| 2件: Venlafaxine Venlafaxine; Venlafaxine Hydrochloride | 2件: D00821
D00821
,
D08670
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 46 |
339 |
Vitamin E
| 2件: Alpha-tocopherol Alpha-tocopherol; Vitamin E | 1件: D02331
D02331
| - | - | 12件: 2 2, 6, 13, 20, 46, 49, 90, 96, 97, 206, 299, 317 |
340 |
Vortioxetine
| 1件: Vortioxetine Vortioxetine | 1件: D10184
D10184
| 7件: HTR1A HTR1A, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E, SLC6A4 💬 | 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
341 |
Warfarin
| 2件: Warfarin Warfarin; Warfarin Sodium | 3件: D00564
D00564
,
D01280
,
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
342 |
Water
| 9件: AVONEX AVONEX; ENBREL; Glucagon; Hiberix; Indocyanine green; OMNITROPE; Sterile Water for Injection; Water; WATER FOR INJECTION | 1件: D00001
D00001
| - | - | 23件: 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
343 |
Wheat
| 1件: Wheat Wheat | 1件: D06902
D06902
| - | - | 3件: 6 6, 98, 266 |
344 |
Wheat bran
| 1件: Wheat bran Wheat bran | - | - | - | 1件: 6 6 |
345 |
Yohimbine
| 1件: Yohimbine Yohimbine | 1件: D08685
D08685
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
346 |
Zoledronic acid
| 4件: Aclasta Aclasta; Zoledronate; Zoledronic acid; Zometa | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 13件: 5 5, 6, 13, 17, 46, 65, 93, 95, 96, 270, 274, 299, 333 |
347 |
Zolmitriptan
| 1件: Zolmitriptan Zolmitriptan | 1件: D00415
D00415
| 2件: HTR1B HTR1B, HTR1D 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
348 |
Zolpidem
| 2件: Zolpidem Zolpidem; Zolpidem Tartrate | 2件: D00706
D00706
,
D08690
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 5 5, 6, 46 |
349 |
Zonisamide
| 2件: Zonegran Zonegran; Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
350 |
Zopiclone
| 1件: Zopiclone Zopiclone | 1件: D01372
D01372
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |